Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
The Lancet. Respiratory Medicine|September 13, 2024
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsCharles S Haworth, Michal Shteinberg, Kevin Winthrop, et al.
The Lancet. Infectious Diseases|January 29, 2022
Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseasesChristoph Lange, Erik C Böttger, Emmanuelle Cambau, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 30, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
RMD Open|October 19, 2022
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseasesKastriot Kastrati, Daniel Aletaha, Gerd R Burmester, et al.
Modern Rheumatology|April 2, 2022
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 yearsNaoki Ishiguro, Yoshiya Tanaka, Tsukasa Matsubara, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
ERJ Open Research|April 3, 2023
Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi studyHuda Asif, Franck F Rahaghi, Akihiro Ohsumi, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Pageof 9